Literature DB >> 3954462

Progressive proliferative glomerulonephritis in a patient with rheumatoid arthritis treated with D-penicillamine.

A J Williams, J N Fordham, C G Barnes, F J Goodwin.   

Abstract

A 49 year old man with rheumatoid arthritis developed a proliferative glomerulonephritis with progressive renal impairment during treatment with D-penicillamine. His renal function continued to deteriorate after the drug was stopped but improved after treatment with corticosteroids and azathioprine.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3954462      PMCID： PMC1001820          DOI： 10.1136/ard.45.1.82

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  6 in total

1.  Penicillamine induced membranous glomerulonephritis.

Authors:  G H Neild; H V Gärtner; A Bohle
Journal:  Scand J Rheumatol Suppl       Date:  1979

2.  D-penicillamine induced Goodpasture's syndrome in Wilson's disease.

Authors:  I Sternlieb; B Bennett; I H Scheinberg
Journal:  Ann Intern Med       Date:  1975-05       Impact factor: 25.391

3.  Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases.

Authors:  D G Scott; P A Bacon; C R Tribe
Journal:  Medicine (Baltimore)       Date:  1981-07       Impact factor: 1.889

4.  Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study.

Authors:  P A Bacon; C R Tribe; J C Mackenzie; J Verrier-Jones; R H Cumming; B Amer
Journal:  Q J Med       Date:  1976-10

5.  D-penicillamine and immune complex deposition.

Authors:  J D Kirby; P A Dieppe; E C Huskisson; B Smith
Journal:  Ann Rheum Dis       Date:  1979-08       Impact factor: 19.103

6.  Extracapillary glomerulonephritis with necrotizing vasculitis in D-penicillamine-treated rheumatoid arthritis.

Authors:  G Banfi; E Imbasciati; L Guerra; M J Mihatsch; C Ponticelli
Journal:  Nephron       Date:  1983       Impact factor: 2.847
  6 in total
  2 in total

1.  Rituximab-induced remission in a woman with coexisting rheumatoid arthritis and nephrotic syndrome.

Authors:  Mia Weiss; Omer Gendelman; Gilad Twig; Ana Tobar; Howard Amital
Journal:  Rheumatol Int       Date:  2015-01-13       Impact factor: 2.631

2.  D-penicillamine-induced glomerulonephritis with crescent formation: Remission following drug discontinuation.

Authors:  S Mokuda; M Onishi; K Takasugi
Journal:  Indian J Nephrol       Date:  2013-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.